Research use only: difference between revisions
Diff·revision 14 → 15·13:52, 21 Dec 2024
Difference between revision 14 and revision 15 of Research use only. 10 lines changed; the page grew by 302 bytes.
| Revision 14 — 17:45, 8 Dec 2024 Compounding_Cate (talk) space between number and unit per PP:MOS 4,757 bytes +35 | Revision 15 — 13:52, 21 Dec 2024 ArchiveBot (talk) bot: expand DOI to full citation 5,059 bytes +302 | ||
|---|---|---|---|
| 8 | | Applied by = The seller | 8 | | Applied by = The seller |
| 9 | | Assessed by = No authority | 9 | | Assessed by = No authority |
| + | 10 | <!-- What it is not --> | |
| + | 11 | | Not = A marketing authorisation | |
| + | 12 | | Not = A manufacturing authorisation | |
| + | 13 | | Not = A statement about identity, purity or sterility | |
| 10 | }} | 14 | }} |
| 11 | {{hatnote|This article describes a labelling category and the legal position around it. It is not legal advice, and nothing on this wiki is medical advice — see [[Project:Medical disclaimer]].}} | 15 | {{hatnote|This article describes a labelling category and the legal position around it. It is not legal advice, and nothing on this wiki is medical advice — see [[Project:Medical disclaimer]].}} |
| ⋮ | ⋮ | ||
| 38 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.</ref> | 42 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.</ref> |
| 39 | <ref name="registry">National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration records, retrieved 2026. Registry records establish existence, address and declared scope of business; they are not a quality assurance.</ref> | 43 | <ref name="registry">National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration records, retrieved 2026. Registry records establish existence, address and declared scope of business; they are not a quality assurance.</ref> |
| + | 44 | ||
| + | 45 | == See also == | |
| + | 46 | * [[Certificate of analysis]] | |
| + | 47 | * [[Bacterial endotoxin test]] | |
| + | 48 | * [[Customs seizure]] | |
| + | 49 | * [[Peptide supply chain]] | |
| 40 | 50 | ||
| 41 | {{DEFAULTSORT:Research use only}} | 51 | {{DEFAULTSORT:Research use only}} |